chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: This report was received concerning a patient who on 5/24/02 was vaccinated with a dose of MMR (second generation). Subsequently, the patient experienced a hypersensitivity reaction. The hypersensitivity reaction was considered to be an other important event (OMIC). No further information is expected.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Drug administration error
Clinical narrative: Information has been received from a 25 year old white female consumer with a penicillin allergy who is a registered nurse.  The reporter indicated that on 12/17/2002, in the pm, she was drawing up a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and may have gotten a little spray in her eye (dilutent lot # 643507/0669M).  She indicated that she was unsure and is not having any problems at this time.  Unspecified medical attention was sought.  Follow-up information from the consumer indicated that while mixing, she got spray in her eyes.  She rinsed her eyes at an eye wash station and no problems ensued.  There were no diagnostic studies or laboratory results.  Additional information has been received from the consumer, who is also a registered nurse, indicating that she did not have any more information, nor could she "provide a lot number."  Additional information is not expected.
Age: 1.2
Sex: F
Vaccine: IPV, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Initial and follow up information has been received from a registered nurse regarding a 14 month old (previously reported as 15 month old) female patient, with no known drug allergies, who on 11/18/2002 was vaccinated with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642645/0527M).  At the same time, the patient received a first dose of varicella virus vaccine live (Lot # 642996/0458M), a third dose of poliovirus vaccine (IPOL)(Lot # U1645) and tuberculin purified protein derivative (PPD Tine Test).  The patient was not ill at the time of vaccination.  On 11/30/2002 the patient developed a rash.  The nurse practitioner saw the patient in the clinic on 12/02/2002 and it was reported that the rash was "viral type" and all over the patient's body, mostly on trunk and arms.  The patient was afebrile (96.0 degrees Fahrenheit) with a normal exam (pulse 100, respirations 16) except for the rash.  The nurse describes the rash as "red pustules" and "measles type".  The mother reported fever.  It was reported that the child was well, active and eating "OK".  The patient was to return to clinic as needed if the rash became itchy or worse.  Subsequently, the patient recovered from the rash.  The patient has had no adverse events following prior vaccinations.  Additional information is not expected.
Sex: M
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse and physician concerning a white male who was vaccinated with a first, second and third dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) IM dates not reported.  The patient "came down with the mumps".  The reporter also reported the patients brother's experience (WAES # 0210USA02068).  Unspecified medical attention was sought.  No further information is expected.
Age: 1.3
Sex: M
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Abnormal behaviour
Clinical narrative: Information has been received from a Physical Therapist who is the mother of a 15 month old male patient who on approximately 10/26/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(no lot number reported).  The patient was concomitantly vaccinated with varicella virus vaccine live and HIB conj-hepatitis B vaccine.  Since vaccination the patient developed behavioral changes that were described as the patient was non-responsive when called and pushed family away when hugged.  The patient also developed diarrhea since vaccination and it was reported that prior to vaccination the patient had a very solid hard stool.  In October 2002 the patient developed croup 6 days post vaccination.  Unspecified attention was sought.  Additional information has been requested.
Age: 50.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a registered nurse concerning a 50 year old male patient who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently the patient had a measles titer of 0.00.  He was given a booster of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and the level went to 0.39.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 14 month old male patient who on 12/17/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 641878/0182M).  On 12/25/2002 the patient developed a measles-like rash.  It was noted that the patient was afebrile and did not require hospitalization.  Unspecified medical attention was sought.  The physician also reported another patient that developed a severe measles rash and swelling in hands and feet (WAES # 0301USA00833).  "MD concerned since probably from the same lot since given in her office on the same day".  The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a pharmacist concerning an adult female client who was vaccinated post-partum with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported) in September 2002 and on 10/21/2002.  Subsequently, the client failed to seroconvert to measles.  Unspecified medical attention was sought.  The reporter was questioning if the patient should be revaccinated. It was noted that the patient is not breast feeding.  Additional information has been requested.
Age: 19.0
Sex: M
Vaccine: MMR, TTOX
Symptoms: Epistaxis
Clinical narrative: Information has been received from a registered nurse concerning a 19 year old male patient who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported) on an unspecified date.  Concomitant therapy that same day included a dose of tetanus vaccine.  Subsequently the patient developed nosebleeds for about two weeks after vaccination.  He had no history of nosebleeds.  His platelet count was reported to be low normal at approximately 140,000 (units and normal values not reported).  The patient had never had a vaccination before as he had been home schooled.  In order to enter college, he needed several vaccinations.  Subsequently the patient "fully recovered" from the nosebleeds.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a registered nurse concerning a 27 year old female patient, with no known drug allergies, who on 01/28/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 639917/0742L).  Follow up information indicates that a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 644083/0877M) was given in the left arm on 02/03/2003.  There was no illness at the time of vaccination.  On 12/26/2002 (also reported as 01/02/2003) the patient's titer was negative for rubella and a lab report indicates a "failure to serconvert."  Lab report from 12/26/2002 included: Measles AB (IGG) 1.21, Mumps AB (IGG) 1.05 and Rubella AB (IGG) <OR=0.90.  Unspecified medical attention was sought.  In follow up information the reporter indicated that "we did not administer the vaccine and there is nothing new to report."  The patient was going to have another measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) administered and titer drawn.  It was reported that "we have no more information".  Additional information is not expected.
Age: 12.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Rash
Clinical narrative: Information has been received from a registered nurse concerning her seven year old son, who in approximately 1997 at the age of approximately 12 months was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the infant developed a rash and a high temperature.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Oedema peripheral, Rash
Clinical narrative: Information has been received from a physician concerning a 1 year old male patient who on 12/17/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 641878/0182M).  Subsequently the patient developed a severe measles rash and swelling in the hands and feet.  A culture (unspecified) was taken and was negative.  It was also reported that the patient was afebrile and did not require hospitalization.  Unspecified medical attention was sought.  The physician also reported another patient that developed a measles-like rash (WAES # .....2USA02437).  The reporter expressed a concern regarding the lot number.  The records of testing prior to release of this lot have been check by Quality Assurance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: HIBV, MMR
Symptoms: Drug ineffective, Laboratory test abnormal
Clinical narrative: Information has been received from a physician concerning a 5 year old white male student with no prior medical history or known allergies who on 08/06/1998, at the age of 15 months, was vaccinated subcutaneously in the right thigh with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 627842/0798M).  Concomitant vaccination on 08/06/1998 included a fourth dose of Haemophilus B conjugate vaccine (ACTHIB)(Lot # 0949110) intramuscularly in the left thigh.  There was no illness at the time of vaccination.  On 06/06/2002 the patient had a negative mumps titer of 0.56.  Titers were drawn because the patient's mother did not want the second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  It was noted that the patient's titers for measles and rubella indicated that he was immune.  Subsequently, the patient was vaccinated in the Spring of 2002 with a 0.5ml dose of mumps virus vaccine live.  Unspecified medical attention was sought.  Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Face oedema, Urticaria
Clinical narrative: Information has been received from a consumer concerning a 15 month old male patient, with food allergies to peanuts, eggs, soy and wheat, who was vaccinated with a diluted dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine (second generation) via pin prick, "NEAT F/S PRICK TEST".  There was no concomitant medication.  Subsequently, it was reported that the patient did have a reaction and developed facial swelling and hives all over his body.  It was reported that the patient was given medication and the symptoms went away.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: MMR
Symptoms: Nonspecific reaction
Clinical narrative: Information has been received from a nurse concerning an 18 year old female patient with asthma nos who on 07/02/1985 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) and subsequent dose on 08/16/1995.  The patient was not ill at the time of vaccination per the reporter.  The lot number was not available, as it was not written down in the patient's chart.  Concomitant therapy included ...ophylline (SLO-BID), inhaler (prn) [therapy unspecified], ethinyl estradiol/norgestimate (ortho-tri-cyclen) and amoxicillin.  On 01/06/2003 the patient's titer was 0.5 for measles and positive for rubella.  Follow up information has been received from a nurse indicating that the "patient did not have an adverse event."  The reporter stated that the patient was antibody negative for rubella (previously reported as positive).  The patient only needed rubella "re-shot" per the reporter.  It was reported that "this was interpreted wrongly" and that "this is not an adverse incident."  The titers were drawn as required for nursing school physical.  The reporter indicated that contact on this "closed case" should be discontinued.  Unspecified medical attention was sought.  Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a registered nurse concerning a female patient who on 05/07/1991 was vaccinated with her second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported).  The patient had previously received a rubella vaccine (Manufacturer unknown) in 1984, mumps vaccine (manufacturer unknown) in 1985 and measles vaccine (manufacturer unknown) in 1986.  Upon entering college, titers were drawn and she was found to have a negative titer.  Unspecified medical attention was sought.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Lymphadenopathy, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male pt who was vaccinated with his first dose of MMR II. Subsequently, the pt developed mumps-like symptoms, including regional lymphadenopathy. No further info was available. Unspecified medical attention was sought. Additional info has been requested.
Sex: U
Vaccine: MMR
Symptoms: Laboratory test abnormal
Clinical narrative: Information has been received from a medical assistant concerning a pt who was vaccinated on an unspecified date with a dose of MMR II. Laboratory evaluation revealed a titer test indicated that the pt was not immune or protected from the measles. Unspecified medical attention was sought. Additional info has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: This report was received from manufacturer for Augmentin Suspension and was assigned manufacturer report number (A0392300A) concerning a 12 month old male pt who was vaccinated on an unspecified date with a dose of MMR II. Additional suspect therapy included amoxicillin trihydrate (+) clavulanate potassium initiated on 1/3/03 for sinusitis. On 1/12/03, the pt's mother reported that her son had developed a "really bad rash from head to toe." It was noted that hte ? was a raised rash that the pt scratched occasionally. He was treated with Benadryl on the advice of the physician and therapy with amoxicillin/clavulanate potassium was discontinued on 1/12/03. According to the pt's mother, the physician felt that the rash was due to the MMR II that the child had recently received and not the amoxicillin trihydrate/clavulanate potassium. "The outcome of the event was reported as unresolved." A consumer, the pt's mother, was the initial reporter. Additional info is not expected.
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a female with no known drug allergies who on approximately 1/15/03 was vaccinated with MMR II. There was no concomitant medication. The RN reported that in January 2003, the pt developed a fever of 103-104. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional  info has been requested.
Age: 1.08
Sex: M
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Information has been received from a medical assistant concerning a 13 month old male with no medical history and no known allergies who on the afternoon of 01/06/2003 was vaccinated in the left leg with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #642702/0350M). There was no concomitant medication, and no illness at the time of vaccination. On 01/30/2003 (also reported as 01/28/2003) the pt developed a rash on his trunk and face. The physician reported  that this case was not just a rash but that it was "vaccinia - a measles like infection that occurs after vaccination accompanied by fever, malaise, rash and coryza." The physician said he had not seen this type of reaction in years and suspects that the vaccine might have been too virulent. The physician requested an investigation into that lot number performed. Unspecified medical attention was sought. The pt recovered on 01/30/2003. The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory. The lot complies with the standard of the Center for Biologics Evaluation and Research was released. It was reported that two other patients received the same vaccine and also developed a measles like infection; (WAES #0302USA00198) and (WAES #0302USA00199). Additional info is not expected.
Age: 1.1
Sex: F
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a physician and a medical assistant concerning a 13 month old female with no medical history, no known allergies and no illness at the time of vaccination.  On 01/13/2003 she was vaccinated in the right leg with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642702/0350M).  There were no concomitant medications.  On 01/22/2003 the patient developed a rash on her trunk and face.  ON 01/23/2003 she presented to the physician's office "with vaccinia-measles induced by MMR post vaccine."  The physician reported that this case was not just a rash but that it was "vaccinia--a measles-like infection that occurs after vaccination accompanied by fever, malaise, rash and coryza."  On 01/28/2003 the rash was gone and the patient was considered recovered.  The physician said he has not seen this type of reaction in years and suspects that the vaccine might have been too virulent.  The physician requested an investigation into that lot number.  The records of testing prior to release of this lot have been checked by GMP Compliance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  It was reported that two other patients received the same vaccine and also developed a measles-like infection (WAES # 0301USA03088) and (WAES # 0302USA00199).  Additional information is not expected.
Age: 1.1
Sex: F
Vaccine: MMR
Symptoms: Infection, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 13 month old female with no medical history and no allergies who on 01/07/2003 was vaccinated into the left leg with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642702/0350M).  The patient was not ill at the time of vaccination.  There was no concomitant medication.  On 01/20/2003 the patient developed a rash on her trunk and face and presented to the office with a "classic measles rash".  The physician reported that this case was not just a rash but that it was "vaccinia--a measles-like infection that occurs after vaccination accompanied by fever, malaise, rash and coryza".  The physician said he has not seen this type of reaction in years and suspects that the vaccine might have been too virulent.  The physician requested an investigation into that lot number.  Unspecified medical attention was sought.  Follow up information from a medical assistant indicates that the patient has recovered.  The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was released.  It was reported that two other patients received the same vaccine and also developed measles like infection; (WAES # 0301USA03088) and (WAES # 0302USA00198).  Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse, via a nursery school administrator, concerning a child (age and gender not reported) who was vaccinated on an unspecified date with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported).  Nine days after vaccination (initially reported as approximately ten days post vaccination) the child developed a rash.  It was reported that "the child was diagnosed as having mild measles."  The nurse reported that she was informed that the parent took the child to the "primary MD" who diagnosed "mild measles".  No further information is available.
Age: 15.0
Sex: F
Vaccine: HIBV, IPV, MMR, TTOX
Symptoms: Rash pruritic
Clinical narrative: Information has been received from a registered nurse concerning a 15 year old female, that had emigrated from Mexico and was getting immunizations on an accelerated schedule, who on 11/26/2002 and on 01/29/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported).  Concomitant medications included hepatitis B vaccine recombinant (yeast)(manufacturer unknown)(Lot # not reported), poliovirus vaccine and tetanus toxoid.  On 11/30/2002 the patient compained of an itchy rash on her lower legs that resolved shortly thereafter.  On 01/29/2003, on hour after receiving the same four vaccines, the patient developed a worse rash on both arms and legs.  She presented to the nurse in the health department where she received the vaccines and it was noted that her rash appeared to have lessened with only itch marks present.  The patient was treated with diphenhydramine hydrochloride (Benadryl).  She had no shortness of breath on either occasion.  Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Convulsion, Electroencephalogram abnormal
Clinical narrative: Information has been received from a consumer and a registered nurse concerning a 4 year old female child with eczema at the time of vaccination, a penicillin allergy, an allergy to amoxicillin, a seizure disorder, a developmental delay and a history of HEADDS and pneumococcal meningitis at 4 months of age. The registered nurse reported that on 2/23/00 the child was vaccinated SC in the left thigh with a first dose of MMR (second generation) (lot # not reported) and on 12/12/02 the child was vaccinated SC in the left thigh with a second dose of MMR (second generation) (lot # 642702/0350). The patient's mother reported that the first dose of MMR (second generation) was in December 1999 and the second dose was on 12/19/02. Concomitant therapy included levetiracetam, oxcarbazepine, and clorazepate dipotassium. The consumer reported that her daughter experienced an unusual increase in the number of seizures that she was having immediately after being vaccinated with the first and second doses of MMR (second generation). The registered nurse reported that the patient experienced increased seizure activity after receiving MMR. NOticed after first MMR, then resolved. Unspecified medical attention was sought. On 12/19/02 the child had a PA and Lateral chest x-ray done for cough, seizure, which revealed that the chest was normal. The child had an electroencephalogram done on 2/25/03, which revealed no rhythms that would normally be seen in a child of this age. There was no occipital dominant rhythm. The tracing was actually quite similar to one performed on 10/30/02, after the child had received lorazepam. It was reported that while the child was awake, there was a mixed frequency background of theta and delta rhythms centrally. Very low-voltage fast activity was seen. There was 1 recorded seizure which began at a lower voltage 5 to 5 Hz spike wave in the left hemisphere, and then gradually generalized. Clinically, right arm flexion and eye movement were noted. The background showed a progression of high-voltage slow spike wave pattern, which was generalized, but of much higher voltage on the left as compared to the right. Th tracings, otherwise, showed frequent multifocal spikes occurring in the left hemisphere. As was previously noted, they were frequent at C3, but also seen at F3, F7, and T5. During brief sleep, a few scattered vertex waves were noted, but no sleep spindles were seen. The overall impression was reported as: nearly constant left hemisphere multifocal spikes; one brief electroencephalographic seizure reported (approximately 90 seconds total); disorganized backgroud both awake and asleep and it was noted overall the tracings was quite similar to what was seen previously. The outcome for these events is unknown. Upon internal review, the increase in the number of seizures was determined to be an other important medical event (OMIC). No further information is expected.
Age: 1.1
Sex: F
Vaccine: DTP, DTPHIB, MMR
Symptoms: Erythema, Feeling hot, Infection, Laboratory test abnormal, Oedema
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old white male child with no past medical history, no allergies and who was well at the time of vaccination.  On 11/11/2002 the child was vaccinated intramuscular in the right leg with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642233/0232M).  Concomitant medications included vaccination intramuscular in the left leg with a fourth dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (DTP VACCINE ADSORBED USP)(Lot # C0947AA) on 11/11/2002 and vaccination intramuscular in the left leg with a fourth dose of Haemophilus B conjugate vaccine (ACTHIB(Haemophilus B conjugate vaccine ))(Lot # UA779AA) on 11/11/2002.  The registered nurse initially reported that on 01/25/2003 the patient developed mumps.  The swelling was unilateral.  As of 02/03/2003 the child still has some swelling but was no longer febrile.  The same nurse reported additional follow up information.  She reported that the mother noticed unspecified symptoms while bathing the child on 01/25/2003 and the patient was seen by the physician on 01/26/2003.  On 01/26/2003 it was noted that the tonsils were mildly enlarged and pink with no exudate.  The area between the left posterior mandible and mastoid had 2 + swelling and slight redness and heat was noted.  "none over mandible" was also reported.  On 01/28/2003 laboratory evaluation revealed that rubella IgG was "immune"; mumps antibodies, IgM was 1.19 (reference ranges noted that > 1.10 was noted to be positive with a note which stated "presence of IgM specified antibody should be interpreted in conjunction with the patient's clinical history and exposure rish when an acute infection is suspected") and mumps antibodies, IgG was 3.95 (reference range noted > or = to 1.10 was positive and a note which stated "presence of antibodies to mumps is presumptive evidence of immunity except when active infection is suspected).  Follow up information from the nurse also noted that on 02/10/2003 the child required an I&D of an abscess over the parotid gland.  Further follow up information from the nurse stated that the child was diagnosed with mumps and the abscess over the parotid gland was secondary to the mumps.  On 04/03/2003 the nurse reported that the patient had recovered.  No further information is expected.
Age: 1.1
Sex: F
Vaccine: DTP, DTPHIB, MMR
Symptoms: Tonsillitis
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old white male child with no past medical history, no allergies and who was well at the time of vaccination.  On 11/11/2002 the child was vaccinated intramuscular in the right leg with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642233/0232M).  Concomitant medications included vaccination intramuscular in the left leg with a fourth dose of diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (DTP VACCINE ADSORBED USP)(Lot # C0947AA) on 11/11/2002 and vaccination intramuscular in the left leg with a fourth dose of Haemophilus B conjugate vaccine (ACTHIB(Haemophilus B conjugate vaccine ))(Lot # UA779AA) on 11/11/2002.  The registered nurse initially reported that on 01/25/2003 the patient developed mumps.  The swelling was unilateral.  As of 02/03/2003 the child still has some swelling but was no longer febrile.  The same nurse reported additional follow up information.  She reported that the mother noticed unspecified symptoms while bathing the child on 01/25/2003 and the patient was seen by the physician on 01/26/2003.  On 01/26/2003 it was noted that the tonsils were mildly enlarged and pink with no exudate.  The area between the left posterior mandible and mastoid had 2 + swelling and slight redness and heat was noted.  "none over mandible" was also reported.  On 01/28/2003 laboratory evaluation revealed that rubella IgG was "immune"; mumps antibodies, IgM was 1.19 (reference ranges noted that > 1.10 was noted to be positive with a note which stated "presence of IgM specified antibody should be interpreted in conjunction with the patient's clinical history and exposure rish when an acute infection is suspected") and mumps antibodies, IgG was 3.95 (reference range noted > or = to 1.10 was positive and a note which stated "presence of antibodies to mumps is presumptive evidence of immunity except when active infection is suspected).  Follow up information from the nurse also noted that on 02/10/2003 the child required an I&D of an abscess over the parotid gland.  Further follow up information from the nurse stated that the child was diagnosed with mumps and the abscess over the parotid gland was secondary to the mumps.  On 04/03/2003 the nurse reported that the patient had recovered.  No further information is expected.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour, Drooling, Excessive eye blinking, Oculogyration, Pruritus
Clinical narrative: This is in follow-up to report(s) previously submitted on 5/30/2003. Information has been received from a consumer and follow up information from someone at a physician's office concerning consumer's son, a 25 month old male with fever and a history of a bladder infection at six months of age who on 11/06/2002 was vaccinated subcutaneously on the left with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(lot # 643500/0633M) (diluent lot # reported to be 0730M). The consumer reported concomitant therapy included acetaminophen (Tylenol) and vitamins (unspecified). The consumer reported that on 11/16/2002 the patient experienced a blank stare in which he would stare straight ahead without blinking or responding to stimuli.  He would then proceed to blink rapidly and press on his eyes. The reporter "suspects that he was experiencing oculogyric crises along with behavioral anomalies." The consumer reported that he also developed a systemic rash consisting of small itchy bumps, fever, chills, and drooling.  Per the consumer, these were not present prior to vaccination.  These symptoms lasted until 12/30/2002.  Unspecified medical attention was sought.  Additional information has been requested. Follow up information received from someone at the physician's office reported that the patient's mother called the physician's office and reported that the patient experienced blinking and questionable drooling one month after receiving the vaccine. The physician office reported that the mother did not bring the child in the physician's office. The consumer reported unspecified medical attention was sought. According to the consumer, these symptoms lasted until 30-DEC-2002. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash pruritic, Staring, Unresponsive to stimuli
Clinical narrative: This is in follow-up to report(s) previously submitted on 5/30/2003. Information has been received from a consumer and follow up information from someone at a physician's office concerning consumer's son, a 25 month old male with fever and a history of a bladder infection at six months of age who on 11/06/2002 was vaccinated subcutaneously on the left with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(lot # 643500/0633M) (diluent lot # reported to be 0730M). The consumer reported concomitant therapy included acetaminophen (Tylenol) and vitamins (unspecified). The consumer reported that on 11/16/2002 the patient experienced a blank stare in which he would stare straight ahead without blinking or responding to stimuli.  He would then proceed to blink rapidly and press on his eyes. The reporter "suspects that he was experiencing oculogyric crises along with behavioral anomalies." The consumer reported that he also developed a systemic rash consisting of small itchy bumps, fever, chills, and drooling.  Per the consumer, these were not present prior to vaccination.  These symptoms lasted until 12/30/2002.  Unspecified medical attention was sought.  Additional information has been requested. Follow up information received from someone at the physician's office reported that the patient's mother called the physician's office and reported that the patient experienced blinking and questionable drooling one month after receiving the vaccine. The physician office reported that the mother did not bring the child in the physician's office. The consumer reported unspecified medical attention was sought. According to the consumer, these symptoms lasted until 30-DEC-2002. Additional information is not expected.
Age: 1.7
Sex: M
Vaccine: MMR
Symptoms: Convulsion
Clinical narrative: information has been received from a consumer concerning a 20 month old male patient, with a history of drug hypersensitivity to antibiotics, including neomycin and a food allergy to fish, who in approximately 1995 was vaccinated with a dose of MMR (second generation) when he was 18 months old. The reporter indicates that two months after receiving the dose of MMR (second generation) the patient had a seizure and was hospitalized. His mother reported that she then found out that the patient was allergic to neomycin. It was also reported that at the time of the patient's experience he was allergic to antibiotics but now he was not. Unspecified medical attention was sought. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  It was reported that the patient subsequently developed measles.  Unspecified medical attention was sought.  Follow up information has been received from a registered nurse indicating that titers were run on the patient and the titers were normal.  Therefore they have determined that the patient did not contract measles.  The reporter states that the adverse event would be disregarded.  Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Thrombocytopenia
Clinical narrative: Information has been received from a registered nurse concerning a pt who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Subsequently, the pt developed thrombocytopenia. Unspecified medical attention was sought. Additional info has been requested.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Rash maculo-papular
Clinical narrative: Information has been received from a nurse concerning an 18 month old male child with a history of eczema who on 02/03/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Within 2 days post vaccination, the child developed a pruritic, macularpapular rash on both legs extending to his abdomen. Treatment was topical cortizone cream. As of 02/13/2003, it was reported that the rash had not decreased and there had been no improvement. Unspecified medical attention was sought. Additional info has been requested.
Age: 29.0
Sex: F
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a registered nurse concerning a 29 year old female employee with multiple "seasonal" allergies (also reported as "possible" allergies) and "was on antibiotic treatment most of the time employed here" who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (dates not available). It was reported that the pt "states she has had all her required shots as a part of ...past employment." On 02/11/2003, the reporter indicated that a recent titer for measles was negative. Follow up info reported that a titer for rubeola was "equivocal". Unspecified medical attention was sought. No further information is expected.  The pt also had a negative titer for varicella post vaccination with varicella virus vaccine live (MSD) (WAES #0302USA01175).
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a 21 year old female pt, with unknown allergies, who "as a child" was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). In 1987, at the age of 21, the pt developed rubella. Unspecified medical attention was sought. Additional info has been requested.
Age: 1.7
Sex: F
Vaccine: MMR
Symptoms: Platelet count decreased, Thrombocytopenia
Clinical narrative: Information has been received from a consumer concerning her 19 month old daughter with no allergies or medical history who on approximately 01/18/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # not reported).  There were no concomitant medications.  Subsequently, the patient experienced thrombocytopenia.  Laboratory evaluation revealed that the patient's platelet levels dropped to 6,000 (normal values not reported).  The patient was admitted to inpatient hospitalization for three days.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a pt who was vaccinated on an unspecified date with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Subsequently the pt developed a rash. Medical attention was not sought. Additional info has been requested.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a registered nurse concerning a 19 year old female pt who on 09/07/1989 and on 04/06/1995 was vaccinated with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Subsequently the pt experienced failure to seroconvert to one or more of the components. Laboratory evaluation by 2 different labs revealed failure to seroconvert. The nurse also reported that 3 other pts (ages and genders not reported) received 2 doses of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported) and failed to seroconvert to one or more of the components. (WAES #0302USA01877). Additional info has been requested.
Age: 48.0
Sex: F
Vaccine: MMR
Symptoms: Pruritus, Rash maculo-papular
Clinical narrative: Information has been received from a physician concerning a 48 year old (previously reported as a 30+ year old) female pt, with no past medical history of allergies, who on 02/04/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #643789/0876M) into the left deltoid. It was reported that the pt may have received a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) as a child. The reporter indicated that 13 days after vaccination, on 02/17/2003, the pt developed a maculopapular rash mainly on the upper trunk. It was reported that the rash was itchy but the pt had no fever, aches or nausea and vomiting. No other symptoms were reported. The pt was not ill at the time of vaccination. There was no known etiology for the rash reported. The pt was treated with diphenhydramine (BENADRYL) 25 mg TID. The pt recovered from her experience in "several days". Unspecified medical attention was sought. Additional info is not expected.
Age: 1.0
Sex: M
Vaccine: HEP, HIBV, MMR, VARCEL
Symptoms: Diarrhoea, Pyrexia, Rash maculo-papular
Clinical narrative: Information has been received from a physician concerning a 12 month old male pt, with no past medical history and no concurrent conditions who was vaccinated SC into the right thigh on 01/06/2003 at 12:30 with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #643391/0506M) (lot #635740/0944M-diluent). Concomitant vaccinations on 01/06/2003 at 12:30 included an IM dose of Haemophilus B conjugate vaccine (ActHIB) (lot #4B345AA) into the right thigh, a SC dose of varicella virus vaccine live (lot #643083/0572M) (MSD) into the left thigh, and an IM dose of hepatitis B vaccine recombinant (ENGERIX-B) (lot #ENG5366A2) into the left thigh. It was reported that the pt developed diarrhea, fever and a maculopapular rash (previously reported as measles) confluent in the neck and face region. It was reported that there was no illness at the time of vaccination. It was also reported that the pt went to the ER. It was reported that the pt recovered. Additional info is not expected.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Pain, Rash
Clinical narrative: Information has been received from a physician concerning his son, a 5 1/2 year old male who was vaccinated on an unspecified date with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Subsequently the pt experienced pain in his legs and a rash. Unspecified medical attention was sought. The pt recovered from the pain in his legs and the rash. The physician also reported that another son experienced a speech impediment which was characterized by stammering and stuttering after vaccination with (+) mumps virus vaccine live (+)rubella virus vaccine live (second generation) (lot # not reported) (WAES #0302USA02465). further information is available.
Age: 11.0
Sex: M
Vaccine: MMR
Symptoms: Oedema, Pain
Clinical narrative: Information has been received from a consumer concerning an 11 year old male who on 02/17/2003 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Subsequently the pt experienced pain and swelling in the injected arm. The school nurse examined the boy and saw no signs of swelling, however the pt was complaining of pain. Unspecified medical attention was sought. Additional info has been requested.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Dysphemia
Clinical narrative: Information has been received from a physician concerning his son, a 42 month old male who was vaccinated on an unspecified date with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). Subsequently the pt experienced a "speech impediment" which was characterized by "stammering and stuttering". The physician reported that this condition returned to "normal" the morning after administration of a "homeopathic detox." The physician also reported that another son experienced pain in his legs and a rash after vaccination with (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported) (WAES #0302USA02304). Additional info has been requested.  Follow up on 12/04/03: "Further follow up obtained from the responsible physician who reported that she was not aware of an adverse event after MMRII as nothing was noted on the child's chart.  She reproted that nothing abnormal had been found on exams and the child has met all of his developmental milestones as appropriate.  IT was noted that the child had been seen the office on 11/10/2001 for a physicial exam and the mother had not mentioned an adverse event after the vaccination.  The physician reported that the child was last seen on 06/28/03 and nothing was reported at that visit either, nor was anything noticed to be abnormal.  The physician also reported that another son experienced pain in his legs, a rash and on follow up reported the pt had experienced a slight limp in right leg after vaccination with MMRII (Lot # not reported) (WAES#0302USA02304).  No further information is available."
Age: 57.0
Sex: F
Vaccine: MMR
Symptoms: Eye inflammation, Ocular hyperaemia
Clinical narrative: Information has been received from a 57 year old female registered nurse regarding herself. She has a history of a diltiazem hydrochloride (Cardizem) allergy, coronary artery disease, hypertension and high cholesterol. On 02/25/2003 at 11:00 AM she was assisting with a vaccination with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #643954/0878M) and the vaccine squirted out of the syringe and the needle into her left eye and face. There was mild burning and slight redness noted. Concomitant therapy included vaccination on 02/11/2003 in the left deltoid (inoculation with 15 sticks) with a third dose of small pox vaccine (Dryvax) (batch #...0077). The measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) vaccine was manually flushed from the eye and face with water. She was referred to a workman's compensation physician and the eye was flushed with 500 cc of sterile water and she was released the same day. No further problems have been noted and she was recovered from these events on 02/25/2003. No further info is expected.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Ophthalmoplegia
Clinical narrative: Information has been received from a nurse practitioner concerning a 34 year old female certified medical assistant who on 02/28/2003 was splashed in both eyes with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot # not reported). The pt reported that her eyes felt numb. Unspecified medical attention was sought. The pt's outcome is unknown. Additional info has been requested.